Trial Profile
Clinical Trials Insight: 700060230
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2010
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary) ; Toremifene (Primary)
- Indications Early breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- 14 Oct 2010 New trial record